 | Up a level |
Nowak, Albina; Dormond, Olivier; Monzambani, Véronique; Huynh-Do, Uyen; Barbey, Frédéric (2022). Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity. Molecular genetics and metabolism, 137(1-2), pp. 173-178. Elsevier 10.1016/j.ymgme.2022.08.003
